Paul Rudick

Paul Rudick has extensive work experience in the pharmaceutical industry. From 2004 to 2019, they worked at Pfizer in the role of Gene Therapy Commercial Development, Prizer Rare Diseases. Since 2019, they have been working as the Vice President at Elucida Oncology, Inc.

Paul Rudick attended Cornell University from 1986 to 1990, where they obtained a Bachelor's degree. Following that, from 1993 to 1995, they pursued an MBA in Finance, General at The Wharton School.